Publications by authors named "YunPeng Liu"

The purification efficiency of autoexhaust carbon strongly depends on the heterogeneous interface structure between active metal and oxide, which can modulate the local electronic structure of defect sites to promote the activation of reactant molecules. Herein, the high-dispersion CuO clusters supported on the well-defined CeO nanorods were prepared using the complex deposition slow method. The formation of heteroatomic Cu-O-Ce interfacial structural units as active sites can capture electrons to achieve activation of the NO and O molecules.

View Article and Find Full Text PDF

Given extremely high porosity, aerogels have demonstrated remarkable advantages in serving as thermal insulation and wave-transparent materials. Unfortunately, their practical applications are greatly confined by their inherent fragility. The recent emergence of polymer aerogels presents an ideal platform for the development of flexible aerogel films.

View Article and Find Full Text PDF
Article Synopsis
  • Intracranial Atherosclerotic Stenosis (ICAS) is a major cause of acute ischemic stroke, and the study investigates how Computed Tomography Perfusion (CTP) can help diagnose and manage it in patients.
  • A retrospective analysis of 224 acute ischemic stroke patients showed that CTP can differentiate ICAS from other stroke causes through specific perfusion parameters, indicating ICAS patients have more salvageable brain tissue.
  • Results suggest that CTP not only improves diagnostic accuracy (with an AUC of 0.7779) but also correlates with better functional outcomes, highlighting its potential role in treatment decisions for ICAS-induced strokes.
View Article and Find Full Text PDF

The 2024 updates of the Chinese Society of Clinical Oncology (CSCO) Clinical Guidelines for the diagnosis and treatment of colorectal cancer emphasize standardizing cancer treatment in China, highlighting the latest advancements in evidence-based medicine, healthcare resource access, and precision medicine in oncology. These updates address disparities in epidemiological trends, clinicopathological characteristics, tumor biology, treatment approaches, and drug selection for colorectal cancer patients across diverse regions and backgrounds. Key revisions include adjustments to evidence levels for intensive treatment strategies, updates to regimens for deficient mismatch repair (dMMR)/ microsatellite instability-high (MSI-H) patients, proficient mismatch repair (pMMR)/ microsatellite stability (MSS) patients who have failed standard therapies, and rectal cancer patients with low recurrence risk.

View Article and Find Full Text PDF

It is now understood that brain metastases do not occur randomly but have distinct spatial patterns depending on the origin of the cancer. According to the "seed and soil" hypothesis, the final colonization of metastatic cells is the result of their adaptation to the altered environment. To investigate the most favorable microenvironment for brain metastasis, we analyzed neuroimaging data from 177 patients with breast cancer brain metastasis and 548 patients with lung cancer brain metastasis to create a replicable probabilistic map of metastatic locations.

View Article and Find Full Text PDF
Article Synopsis
  • A phase 3 trial (CHOICE-01) showed that combining toripalimab with chemotherapy significantly improves progression-free survival (PFS) in patients with advanced non-small cell lung cancer (NSCLC).
  • The final analysis revealed a median overall survival (OS) of 23.8 months for the toripalimab group compared to 17.0 months for the control group, particularly benefiting non-squamous patients.
  • The study also emphasized the role of circulating tumor DNA (ctDNA) and tissue-based sequencing in identifying biomarkers that predict treatment efficacy, suggesting continuous ctDNA monitoring could enhance personalized treatment strategies.
View Article and Find Full Text PDF

In hepatocellular carcinoma (HCC), lenvatinib is a key first-line treatment that significantly improves survival in some patients with advanced stage. However, lenvatinib resistance presents a major clinical challenge. This study aims to identify key molecular factors driving lenvatinib resistance in HCC and propose intervention strategies to overcome this resistance, thereby enhancing therapeutic efficacy.

View Article and Find Full Text PDF

The study investigated the effects of a toughening agent and micron-sized toughening particles (TP) on the resin and carbon fiber-reinforced polymer (CFRP) composites, with a particular focus on compressive strength. The results showed that the addition of the toughening agent improved the overall mechanical properties of both the resin and CFRP but had a minor effect on the residual compressive strength (CAI) of CFRP after impact. Compared to the pure toughening agent, the addition of TP increased the CAI, GIC, and GIIC of CFRP by 74%, 35%, and 68%, respectively.

View Article and Find Full Text PDF
Article Synopsis
  • Designing π-conjugated conductive polymers with redox-active groups can improve charge storage in aqueous energy devices.
  • The electropolymerization of s-triazine on carbon cloth leads to a polytriazine-coated electrode that demonstrates strong charge storage capabilities, achieving specific capacities of 101.4 mAh g-1 in acidic solution and 50.3 mAh g-1 in zinc sulfate.
  • A device using these electrodes shows impressive energy and power densities, and maintains 83.3% capacity after 2500 cycles, suggesting that polytriazine is a promising material for future energy storage applications.
View Article and Find Full Text PDF

Background: IAH0968 is an afucosylated anti-epidermal growth factor receptor 2 (HER2) monoclonal antibody which improved the activity of antibody-dependent cellular cytotoxicity (ADCC) and superior anti-tumor efficacy.

Methods: To determine the maximum tolerated dose (MTD) with dose-limiting toxicity (DLT), a single institution, phase Ia/Ib study was undertaken, using 3 + 3 design. The primary endpoints were safety, tolerability and preliminary clinical activity.

View Article and Find Full Text PDF
Article Synopsis
  • A phase 3 study showed that combining camrelizumab with chemotherapy significantly improved progression-free survival in patients with advanced non-squamous non-small-cell lung cancer compared to chemotherapy alone.
  • After 5 years, overall survival rates were 31.2% for those receiving camrelizumab and chemotherapy versus 19.3% for those on chemotherapy alone, indicating a substantial benefit.
  • Patients who completed two years of treatment with camrelizumab had an impressive 5-year overall survival rate of 84.3%, reinforcing its effectiveness and safety as a first-line therapy for this cancer type.
View Article and Find Full Text PDF
Article Synopsis
  • Biomass-based flame retardants are gaining attention for their environmental benefits, but creating eco-friendly and effective methods for synthesizing them for epoxy resins (EP) is challenging.
  • This research successfully develops a new flame retardant (MMCA) derived from chitosan and phytic acid, achieving a UL-94 V-0 rating with just 5 wt% incorporation into EP, thanks to its ability to form a protective char layer during combustion.
  • The addition of MMCA also significantly reduced smoke and heat release during fires and improved the mechanical properties of EP, highlighting a sustainable approach to enhancing fire safety and material performance.
View Article and Find Full Text PDF

Antibody-drug conjugates (ADCs) have emerged as a powerful avenue in the therapeutic treatment of cancer. Site-specific antibody-drug conjugations represent the latest trend in the development of ADCs, addressing the limitations of traditional random conjugation technologies. This article summarizes the innovative development of Fc-glycan-specific ADCs (gsADCs), which utilize the conserved Fc -glycan as the anchor point for site-specific conjugation.

View Article and Find Full Text PDF

Introduction: Patients with anaplastic lymphoma kinase (ALK)-positive NSCLC developing resistance to second-generation inhibitors have limited treatment options. Deulorlatinib is a highly brain-penetrant, new-generation ALK/ROS1 inhibitor. We evaluated the safety, efficacy, and pharmacokinetics of deulorlatinib in ALK-positive NSCLC.

View Article and Find Full Text PDF

Acute alcohol consumption has been found to cause duration perception distortions, but the directions of these distortions are not consistent. The mechanisms underlying this effect are also unclear. The present study seeks to elucidate the effect of acute alcohol consumption on duration perception and the mechanisms involved.

View Article and Find Full Text PDF

Importance: Patients with extensive-stage small cell lung cancer (ES-SCLC) have poor prognoses and unmet medical needs.

Objective: To evaluate the efficacy and safety of toripalimab plus etoposide and platinum-based chemotherapy (EP) vs placebo plus EP as a first-line treatment for patients with ES-SCLC.

Design, Setting, And Participants: This multicenter, double-blind, placebo-controlled phase 3 randomized clinical trial (EXTENTORCH study) enrolled patients from September 26, 2019, to May 20, 2021, and was conducted at 49 sites in China.

View Article and Find Full Text PDF

This study is dedicated to the development of a new type of cesium tungsten bronze energy-saving laminated glass and explores its application in insulating glass combinations, offering innovative ideas and practical solutions for advancing energy-saving glass technology. Experimental results show that both CsWO (CWO) dispersions exhibit good visible light transmittance and near-infrared shielding properties, with CWO1 demonstrating superior shielding in the 650-950 nm range, attributed to differences in shape and size distribution and verified by simulations using the Drude-Lorentz model and the finite element method.

View Article and Find Full Text PDF

This research suggests using landfill gas, derived from landfilling operations, as a feasible alternative to fossil fuels. This study introduces a novel and all-encompassing method for utilizing landfill biogas. The proposed system utilizes a supercritical Brayton cycle with carbon dioxide as the working fluid, a transcritical CO cycle, two ammonia Rankine cycles, a single-effect desalination cycle, a proton exchange membrane electrolyzer, and an improved Kalina cycle.

View Article and Find Full Text PDF

Immunotherapy has transformed the management of hepatocellular carcinoma (HCC), but effectiveness varies among patients. This study aimed to identify biomarkers and HCC subtypes responsive to immunotherapy. Patients were classified into Immunity-High (Immunity-H) and Immunity-Low (Immunity-L) subtypes using ssGSEA scores.

View Article and Find Full Text PDF

The collective behavior of bacteria is regulated by quorum sensing (QS). Autoinducer-2 (AI-2) is a common QS signal that regulates the behavior of both Gram-positive and Gram-negative bacteria. Despite the plethora of processes described to be influenced by AI-2 in diverse Gram-negative bacteria, the AI-2-regulated processes in Bacilli are relatively unexplored.

View Article and Find Full Text PDF
Article Synopsis
  • The tumor microenvironment (TME) significantly affects the success of treatments for hepatocellular carcinoma (HCC), specifically highlighting the role of tumor-associated endothelial cells (TECs) that influence tumor development and treatment response.
  • A study using multi-omics profiling investigated different TEC subpopulations in HCC, uncovering a new subset, CXCL12 TECs, that suppresses immune responses by preventing T cell activation and attracting immune-suppressive cells.
  • Targeting CXCL12 TECs with a bispecific antibody aimed at both CXCL12 and PD1 shows potential to enhance anti-tumor immune responses, representing a promising strategy to improve HCC immunotherapy outcomes.
View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to determine the most effective first-line treatment for advanced hepatocellular carcinoma by systematically analyzing phase III trials over a significant period.
  • A total of 17 studies involving over 10,000 patients were included, revealing that Hepatic artery infusion chemotherapy with oxaliplatin plus fluorouracil (HAIC-FO) provided notable overall survival benefits compared to other treatments like immune checkpoint inhibitors and traditional chemotherapy.
  • HAIC-FO ranked highest in overall survival and objective response rate, while also performing well in progression-free survival, though it didn't outperform certain other combination therapies like lenvatinib with transcatheter arterial chemoembolization.
View Article and Find Full Text PDF

Objectives: To identify the 5' untranslated region of Zika virus (ZIKV 5'UTR) RNA-binding proteins and to investigate the impact of the binding protein on the activity of internal ribosomal entry site (IRES) located in ZIKV 5'UTR and virus production.

Methods: Interacting proteins in U251 cells were captured using tRSA-tagged ZIKV 5'UTR RNA and tRSA-ZIKV 5'UTR RNA-binding proteins were visualized by SDS-PAGE silver staining. Subsequently, liquid chromatography-tandem mass spectrometry (LC-MS/MS), bioinformatics analysis, and Western blot were used to identify the candidate proteins binding to ZIKV 5'UTR.

View Article and Find Full Text PDF

A precious metal catalyst with loaded Pt single atoms was prepared and used for the complete oxidation of CHO. Detailed results show that the T of the 1.5Pt SA/γ-AlO catalyst in the oxidation process of acetone is 250 °C, the TOF of Pt is 1.

View Article and Find Full Text PDF
Article Synopsis
  • DP303c is an investigational antibody-drug conjugate (ADC) designed to target HER2-positive tumors, showing potentially better antitumor activity than the existing treatment T-DM1 in early studies.
  • In a Phase 1 trial in China, 94 patients with advanced HER2-positive solid tumors received varying doses of DP303c, with the focus on assessing safety, tolerability, and determining a recommended dose for future studies.
  • Results indicated that DP303c had promising anti-tumor effects, particularly in breast cancer, with 42.9% of patients achieving an objective response, while an acceptable safety profile was noted, leading to the conclusion that a dose of 3.0 mg/kg every
View Article and Find Full Text PDF